Please assess the completion status of the following clinical trial:

Trial Title: The Trauma of Betrayal: Treating Adjustment Disorder With Reconsolidation Blockade Under Propranolol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of an adjustment disorder or chronic adjustment disorder, as defined by the Diagnostic and Statistical Manual for Mental Disorders, as a result of an attachment injury, defined as an event involving the perceived betrayal, violation of trust, or abandonment by a significant other.~* Currently experiencing clinically important psychological distress as a result of the event, as defined by a score of at least 22 on the IES-R, and a score of at least moderately ill on the Clinical Global Impressions - Severity of Illness Scale.~* Must have been in the romantic relationship for at least 6 months prior to the event.~* Must not take psychotropic medication.~* Fluency in English or French~Exclusion Criteria:~* Systolic blood pressure \<100 mm Hg;~* Cardiac rhythm below 55 beats per minute;~* A medical condition that contraindicates the administration of propranolol, e.g., Asthma, chronic obstructive pulmonary disease, cardiac insufficiency, cardiac choc, Second- or third-degree atrioventricular block, diabetes, spastic angina, auricular sinus illness, bradycardia, Raynaud's disease, severe peripheral vascular disease, untreated Pheochromocytoma, arterial hypotension, previous anaphylactic allergic shock;~* Previous adverse reaction to, or non-compliance with, beta-blocker;~* Current use of a substance that may involve potentially dangerous interactions with propranolol, including P450 2D6 inhibitors.~* Women who are pregnant or breast feeding;~* Individuals currently participating in any other form of psychotherapy (other than strictly supportive).~* History of substance dependence disorder, bipolar disorder, or psychotic disorder;~* Participants judged (based on history, mental status exam, clinical impression, or the Suicidal Behaviors Questionnaire as being at significant risk of suicidal behavior.~* Participation in another drug trial within 30 days prior to the screening visit~* Presence of any clinical condition that might interfere with the interpretation of the efficacy and safety results.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Propranolol pill + mismatch memory reactivation (Type: EXPERIMENTAL): Prediction-error will be incorporated into each treatment sessions.
- Propranolol pill + standard memory reactivation (Type: EXPERIMENTAL): None
- Waitlist (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).